ATOS
ATOS clinical trials: ATOSSA THERAPEUTICS, INC.
Every trial on ClinicalTrials.gov where ATOSSA THERAPEUTICS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ATOS on the catalyst calendar · ATOS registry changes
- Primary completion Jun 2028Sponsor estimatePhase 2NCT07869732(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious PubertyAtossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependentNot yet recruitingATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimatePhase 2NCT05607004(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerAtossa Therapeutics, Inc. · Breast NeoplasmsActive, not recruitingATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 14, 2024ActualPhase 2NCT05068388Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast DensityAtossa Therapeutics, Inc. · Breast DensityCompletedATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 13, 2020ActualPhase 2NCT02540330A Pre-Surgical PK Study of IM and Intraductally Delivered FulvestrantAtossa Therapeutics, Inc. · Female Breast CarcinomaTerminatedATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2011ActualNo phase registeredNCT02121873The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and LavageAtossa Therapeutics, Inc. · Breast CancerCompletedATOSLeadILMNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 10, 2018ActualPhase 2NCT04616430Topical Endoxifen in WomenAtossa Therapeutics, Inc. · Mammographic Breast DensityCompletedATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 8, 2020ActualPhase 1NCT04519788AT-301 Nasal Spray in Healthy AdultsAtossa Therapeutics, Inc. · HealthyCompletedATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2014ActualNo phase registeredNCT02218385ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate FluidAtossa Therapeutics, Inc. · Breast NeoplasmsCompletedATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015Sponsor estimatePhase 3NCT02539615A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years OldAtossa Therapeutics, Inc. · Breast Cancer, Preneoplastic Conditions, BRCAWithdrawnATOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner